# Ophthalmology Referral

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Ray Charles (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ML009-SYN
- Date: 2026-03-03
- Fictional facility: St. Posthumous Health Center
- Fictional author: Gloria Fenwick, MD
- Calendar frame: modern shifted

- To: Haruto Ishikawa, MD, Ophthalmology
- Urgency: Routine, within four weeks, on the same day as his four-week primary care check

## Referral question

Blindness of both eyes since early childhood, with no light perception, in a 65-year-old man new to the practice. The cause was never diagnosed; glaucoma is often suggested. Please examine the eyes for comfort and complications and advise whether eye pressure needs checking or treatment, and what eye care he needs from here. **S**

## Questions for the consultant

1. Is there any active eye disease, such as inflammation, exposure, or raised pressure causing pain, that needs treatment now?
2. In eyes with no light perception and no pain, should eye pressure be measured or lowered?
3. What eye surveillance does he need, and how often?
4. Which symptoms should bring him back urgently?
5. Would any vision rehabilitation services help him now?

## Pertinent history

Gradual loss of sight from about age five, blind by age seven; no eye care on record in recent years. No light perception today. He reports no eye pain, redness, discharge, or headache around the eyes, and uses no eye drops. Lids and ocular surfaces look quiet on primary care examination. Independent in all daily activities using nonvisual methods and a screen reader. Opioid use disorder in sustained remission for more than thirty years without medication; naloxone nasal spray prescribed today. PHQ-9 2. No other medicines. Please send the report as an accessible electronic document; he reads with a screen reader, and he asks that each step of the examination be described before it is done. **S**

- Ray Charles Robinson was born in Albany, Georgia, on September 23, 1930; his mother moved him as an infant to Greenville, a small town in north Florida. **D**
- Charles began to lose his sight at about age five and was blind by age seven; after he was declared legally blind, he was enrolled at the Florida School for the Deaf and Blind in St. Augustine, where he remained for nine years. **D**
- The cause of his blindness is uncertain. It is described as probably congenital juvenile glaucoma, and glaucoma is often mentioned as the cause, but Charles said that nothing was ever diagnosed. **R**
- In 1964 Charles was arrested for possession of heroin, and he later admitted that he had been addicted since the late 1940s. After a period of rehabilitation at a California sanitarium he stopped using drugs and received a five-year suspended sentence. **D**
- Charles struggled with heroin addiction for nearly 20 years and quit "cold turkey" in 1965, after an arrest at the Boston airport. He later became reluctant to discuss his drug use, fearing it would taint how people viewed his work. **D**
- In the year Charles began to lose his sight, his younger brother drowned. His mother died in 1945. **D**

1 later historical claim is omitted because it describes events after the index age. See the teaching note.

Baseline: Hemoglobin: 14.2 g/dL; Sodium: 139 mmol/L; Potassium: 4.2 mmol/L; Creatinine: 0.98 mg/dL; eGFR: 84 mL/min/1.73 m²; Glucose: 94 mg/dL; Calcium: 9.4 mg/dL; Total cholesterol: 186 mg/dL; HDL cholesterol: 54 mg/dL; LDL cholesterol: 110 mg/dL; Triglycerides: 110 mg/dL; HbA1c: 5.5%; PHQ-9: 2; AUDIT-C: 2; DAST-10: 0. All results are synthetic.

BP 128/78 mmHg; pulse 68 bpm; respirations 14/min; temperature 36.7 °C; oxygen saturation 98% on room air; weight 80 kg; BMI 25.2 kg/m². All vital signs are synthetic.

## Current medications

- Naloxone 4 mg nasal spray, one spray in one nostril for a suspected opioid overdose; may repeat every 2 to 3 minutes in alternating nostrils **S**

## Plan so far

- Disability-competent care at every visit: introductions and spoken orientation, describing each step of the examination, offering an arm for guiding, and all documents in an accessible electronic format. Guideline: Vision Rehabilitation Preferred Practice Pattern (2023) **S**
- Recovery-oriented care: ask about cravings, triggers, and any return to use at each visit in a non-judgmental way; naloxone at home and when traveling; recovery supports he can reach; and a written plan for any future pain. Guideline: VA/DoD Clinical Practice Guideline for the Management of Substance Use Disorders (2021); The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update (2020) **S**
- Depression screening with the PHQ-9 at intake and at six months, PHQ-2 at the wellness visit, and a safety review with the 988 Suicide & Crisis Lifeline at each visit. Guideline: Depression and Suicide Risk in Adults: Screening (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, glaucoma and depression, bipolar, and mood disorders monographs (2026) **S**
- Medicine labeling: audio labels from the pharmacy, a braille label on the naloxone, and the same pharmacy for every prescription. Guideline: Vision Rehabilitation Preferred Practice Pattern (2023) **S**
- Fall prevention: CDC STEADI screen at each visit, keeping the home layout unchanged, and a sighted guide in unfamiliar places. Guideline: Vision Rehabilitation Preferred Practice Pattern (2023) **S**
